BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9221799)

  • 1. Group II phospholipase A2 is increased in peritoneal and pleural effusions in patients with various types of cancer.
    Abe T; Sakamoto K; Kamohara H; Hirano Y; Kuwahara N; Ogawa M
    Int J Cancer; 1997 Jun; 74(3):245-50. PubMed ID: 9221799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical trauma induces group II phospholipase A2 production by neutrophils at a local site after surgery.
    Abe T; Sakamoto K; Mita S; Kamohara H; Hirano Y; Kuwahara N; Ogawa M
    Clin Biochem; 1998 Mar; 31(2):101-6. PubMed ID: 9622773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of group II phospholipase A2 in the human gastrointestinal tract.
    Nevalainen TJ; Grönroos JM; Kallajoki M
    Lab Invest; 1995 Feb; 72(2):201-8. PubMed ID: 7853853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of group II phospholipase A2 in human breast cancer tissues is closely associated with their malignant potency.
    Yamashita S; Yamashita J; Ogawa M
    Br J Cancer; 1994 Jun; 69(6):1166-70. PubMed ID: 8198986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of group II phospholipase A2 in the liver in acute pancreatitis.
    Talvinen KA; Kemppainen EA; Nevalainen TJ
    Scand J Gastroenterol; 2001 Nov; 36(11):1217-21. PubMed ID: 11686224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma.
    Gorovetz M; Baekelandt M; Berner A; Trope' CG; Davidson B; Reich R
    Gynecol Oncol; 2006 Dec; 103(3):831-40. PubMed ID: 16919315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group II phospholipase A2 in human male reproductive organs and genital tumors.
    Kallajoki M; Alanen KA; Nevalainen M; Nevalainen TJ
    Prostate; 1998 Jun; 35(4):263-72. PubMed ID: 9609549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholipase A2 isoforms are altered in chronic pancreatitis.
    Kashiwagi M; Friess H; Uhl W; Graber H; Duarte R; Zimmermann A; Büchler MW
    Ann Surg; 1998 Feb; 227(2):220-8. PubMed ID: 9488520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of group II phospholipase A2 protein and mRNA in rat tissues.
    Nyman KM; Ojala P; Laine VJ; Nevalainen TJ
    J Histochem Cytochem; 2000 Nov; 48(11):1469-78. PubMed ID: 11036090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression of group II phospholipase A2 in intestine in ulcerative colitis.
    Haapamäki MM; Grönroos JM; Nurmi H; Alanen K; Kallajoki M; Nevalainen TJ
    Gut; 1997 Jan; 40(1):95-101. PubMed ID: 9155583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression of group II phospholipase A2 in intestine in Crohn's disease.
    Haapamäki MM; Grönroos JM; Nurmi H; Alanen K; Nevalainen TJ
    Am J Gastroenterol; 1999 Mar; 94(3):713-20. PubMed ID: 10086656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer cells isolated from malignant pleural and peritoneal effusions inhibit phospholipase A2 activity in human polymorphonuclear leukocytes.
    Abe M; Kitsuki H; Saruwatari S; Asoh H; Sakurada T; Kuwata H; Nakatani Y; Kudo I; Furukawa T
    Cancer Lett; 1997 Dec; 121(2):155-61. PubMed ID: 9570353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of group II phospholipase A2 in human hepatocellular carcinoma.
    Ying Z; Tojo H; Komatsubara T; Nakagawa M; Inada M; Kawata S; Matsuzawa Y; Okamoto M
    Biochim Biophys Acta; 1994 May; 1226(2):201-5. PubMed ID: 8204668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new pathophysiologic concept in chronic pancreatitis: tissue destruction induced via inflammatory mediators].
    Friess H; Kashiwagi M; Uhl W; Schilling M; Zimmermann A; Büchler MW
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):431-6. PubMed ID: 14518291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effusions rich in amylase without pancreatitis. 14 cases].
    Saugier B; Emonot A; Plauchu M; Galy P
    Nouv Presse Med; 1976 Dec; 5(41):2777-80. PubMed ID: 995607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lactate dehydrogenases in malignant and non-malignant diseases.
    Oladipo OO; Ajala MO; Afonja OA
    Niger Postgrad Med J; 2002 Mar; 9(1):1-6. PubMed ID: 11932752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
    Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of human group II phospholipase A2 in transgenic mice.
    Nevalainen TJ; Laine VJ; Grass DS
    J Histochem Cytochem; 1997 Aug; 45(8):1109-19. PubMed ID: 9267471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 differentially modulates chondrocyte expression of cyclooxygenase-2 and phospholipase A2.
    Lyons-Giordano B; Pratta MA; Galbraith W; Davis GL; Arner EC
    Exp Cell Res; 1993 May; 206(1):58-62. PubMed ID: 8482360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymes in benign and malignant effusions.
    Teloh HA
    Ann Clin Lab Sci; 1977; 7(4):361-3. PubMed ID: 900863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.